Elective Impairment Minus Elective Disability: The Social Model of Disability and Body Integrity Identity Disorder.


Journal

Journal of bioethical inquiry
ISSN: 1872-4353
Titre abrégé: J Bioeth Inq
Pays: Netherlands
ID NLM: 101250741

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 14 02 2019
accepted: 04 12 2019
pubmed: 21 12 2019
medline: 15 4 2021
entrez: 21 12 2019
Statut: ppublish

Résumé

Individuals with body integrity identity disorder (BIID) seek to address a non-delusional incongruity between their body image and their physical embodiment, sometimes via the surgical amputation of healthy body parts. Opponents to the provision of therapeutic healthy-limb amputation in cases of BIID make appeals to the envisioned harms that such an intervention would cause, harms such as the creation of a lifelong physical disability where none existed before. However, this concept of harm is often based on a normative biomedical model of health and disability, a model which conflates amputation with impairment, and impairment with a disability. This article challenges the prima facie harms assumed to be inherent in limb amputation and argues in favour of a potential treatment option for those with BIID. To do this, it employs the social model of disability as a means to separate the concept of impairment and disability and thereby separate the acute and chronic harms of the practice of therapeutic healthy-limb amputation. It will then argue that provided sufficient measures are put in place to ensure that those with atypical bodily constructions are not disadvantaged, the chronic harms of elective amputation would cease to be.

Identifiants

pubmed: 31858387
doi: 10.1007/s11673-019-09959-5
pii: 10.1007/s11673-019-09959-5
pmc: PMC7260267
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

145-155

Références

J Neuropsychol. 2009 Sep;3(Pt 2):181-200
pubmed: 19338723
Soc Sci Med. 1999 Apr;48(8):977-88
pubmed: 10390038
Dev Med Child Neurol. 2016 May;58(5):508-15
pubmed: 26483095
BMJ. 2013 Oct 25;347:f6426
pubmed: 24163087
BMJ. 2000 Feb 5;320(7231):332
pubmed: 10657312
Compr Psychiatry. 2005 Sep-Oct;46(5):380-3
pubmed: 16122539
J Med Ethics. 2009 Sep;35(9):541-5
pubmed: 19717692
J Appl Philos. 2005;22(1):75-86
pubmed: 15948330
Cogn Behav Neurol. 2012 Mar;25(1):34-41
pubmed: 22353728
Psychol Med. 2005 Jun;35(6):919-28
pubmed: 15997612
HEC Forum. 2014 Sep;26(3):225-36
pubmed: 25108391
Am J Bioeth. 2009 Jan;9(1):36-43
pubmed: 19132621
PLoS One. 2012;7(4):e34702
pubmed: 22514657
Ethics. 2005 Oct;116(1):77-99
pubmed: 16578952
J Health Soc Behav. 1978 Mar;18(1):36-45
pubmed: 641330
Case Rep Ophthalmol. 2017 Mar 1;8(1):124-136
pubmed: 28611645
J Hand Surg Br. 2006 Dec;31(6):593-5
pubmed: 16928413

Auteurs

Richard B Gibson (RB)

Centre for Social Ethics and Policy, The University of Manchester Law School, University of Manchester, Manchester, M13 9QQ, UK. Richard.Gibson@manchester.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH